These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11738577)

  • 1. Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARalpha-selective activators.
    Miyachi H; Nomura M; Tanase T; Takahashi Y; Ide T; Tsunoda M; Murakami K; Awano K
    Bioorg Med Chem Lett; 2002 Jan; 12(1):77-80. PubMed ID: 11738577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators.
    Nomura M; Tanase T; Ide T; Tsunoda M; Suzuki M; Uchiki H; Murakami K; Miyachi H
    J Med Chem; 2003 Aug; 46(17):3581-99. PubMed ID: 12904063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of a novel series of alpha-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) alpha/delta dual agonists for the treatment of metabolic syndrome.
    Kasuga J; Yamasaki D; Araya Y; Nakagawa A; Makishima M; Doi T; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Dec; 14(24):8405-14. PubMed ID: 16996742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantio-dependent binding and transactivation of optically active phenylpropanoic acid derivatives at human peroxisome proliferator-activated receptor alpha.
    Miyachi H; Nomura M; Tanase T; Suzuki M; Murakami K; Awano K
    Bioorg Med Chem Lett; 2002 Feb; 12(3):333-5. PubMed ID: 11814790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists.
    Kasuga J; Makishima M; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2006 Feb; 16(3):554-8. PubMed ID: 16275077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the critical structural determinant(s) of species-selective peroxisome proliferator-activated receptor alpha (PPAR alpha)-activation by phenylpropanoic acid-type PPAR alpha agonists.
    Miyachi H; Uchiki H
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3145-9. PubMed ID: 12951082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling study of species-selective peroxisome proliferator-activated receptor (PPAR) alpha agonist; possible mechanism(s) of human PPARalpha selectivity of an alpha-substituted phenylpropanoic acid derivative (KCL).
    Uchiki H; Miyachi H
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):365-7. PubMed ID: 14993764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivative, a selective agonist for human peroxisome proliferator-activated receptor alpha.
    Nomura M; Tanase T; Miyachi H
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2101-4. PubMed ID: 12127513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists.
    Ban S; Kasuga J; Nakagome I; Nobusada H; Takayama F; Hirono S; Kawasaki H; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2011 May; 19(10):3183-91. PubMed ID: 21530275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors.
    Johnson TE; Holloway MK; Vogel R; Rutledge SJ; Perkins JJ; Rodan GA; Schmidt A
    J Steroid Biochem Mol Biol; 1997; 63(1-3):1-8. PubMed ID: 9449199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of a new class of peroxisome proliferator-activated receptor modulators.
    Thor M; Beierlein K; Dykes G; Gustavsson AL; Heidrich J; Jendeberg L; Lindqvist B; Pegurier C; Roussel P; Slater M; Svensson S; Sydow-Bäckman M; Thornström U; Uppenberg J
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3565-7. PubMed ID: 12443777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationship.
    Ohashi M; Oyama T; Nakagome I; Satoh M; Nishio Y; Nobusada H; Hirono S; Morikawa K; Hashimoto Y; Miyachi H
    J Med Chem; 2011 Jan; 54(1):331-41. PubMed ID: 21128600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design and synthesis of subtype- and species-selective peroxisome proliferator-activated receptor (PPAR) alpha ligands].
    Miyachi H
    Yakugaku Zasshi; 2004 Nov; 124(11):803-13. PubMed ID: 15516807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
    Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
    J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
    Xu Y; Rito CJ; Etgen GJ; Ardecky RJ; Bean JS; Bensch WR; Bosley JR; Broderick CL; Brooks DA; Dominianni SJ; Hahn PJ; Liu S; Mais DE; Montrose-Rafizadeh C; Ogilvie KM; Oldham BA; Peters M; Rungta DK; Shuker AJ; Stephenson GA; Tripp AE; Wilson SB; Winneroski LL; Zink R; Kauffman RF; McCarthy JR
    J Med Chem; 2004 May; 47(10):2422-5. PubMed ID: 15115385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and in vitro evaluation of a series of α-substituted phenylpropanoic acid PPARγ agonists to further investigate the stereochemistry-activity relationship.
    Ohashi M; Nakagome I; Kasuga J; Nobusada H; Matsuno K; Makishima M; Hirono S; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2012 Nov; 20(21):6375-83. PubMed ID: 23022278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.
    Ebdrup S; Pettersson I; Rasmussen HB; Deussen HJ; Frost Jensen A; Mortensen SB; Fleckner J; Pridal L; Nygaard L; Sauerberg P
    J Med Chem; 2003 Apr; 46(8):1306-17. PubMed ID: 12672231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise and efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivatives: dual agonists for human peroxisome proliferator-activated receptor alpha and delta.
    Kasuga J; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2006 Feb; 16(4):771-4. PubMed ID: 16321522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a series of oxadiazole-substituted alpha-isopropoxy phenylpropanoic acids with activity on PPARalpha, PPARgamma, and PPARdelta.
    Liu KG; Smith JS; Ayscue AH; Henke BR; Lambert MH; Leesnitzer LM; Plunket KD; Willson TM; Sternbach DD
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2385-8. PubMed ID: 11527737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists.
    Jaradat MS; Noonan DJ; Wu B; Avery MA; Feller DR
    Planta Med; 2002 Aug; 68(8):667-71. PubMed ID: 12221584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.